Heptromic. Genomic predictors and oncogenic drivers in hepatocellurlar carcinoma

  • Heptromic Genomic predictors and oncogenic drivers in hepatocellular carcinoma. Watch the video
  • Heptromic will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
  • Heptromic’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
  • Heptromic is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.


  • CommHERE - Invitation to HorizonHealth launch




    Web for the public
    The EU project Communicating European Health Research, CommHERE, invites you to the official opening of a new health research web portal, targeting the general public. The portal will put European citizens in touch with research by presenting FP7 Health research in an attractive and inspiring way.
    Join our network
    The launch of the web portal is a crucial part of the CommHERE project, enabling dissemination of research on a European level. From working on local levels at the CommHERE partner institutions, we now open up and invite all EU health research
    projects to participate in our communication
    CommHERE in short:
    • Aims to improve communication on the outcome of EU funded health research projects to the media, general public and other target groups, including the EC in all of Europe and beyond.
    • Works by supporting and encouraging
    researchers to communicate also outside of the scientific community.
    • Duration: 36 months, from October 2011 to September 2014
    • Funding: 2 million Euro
    • Project web site: www.commhere.eu

  • Dr. Augusto Villanueva and Dr. Francesc Balaguer awarded Rising Stars by United European Gastroenterology (UEG) National Societies

     Every year the United European Gastroenterology (UEG) National Societies Committee and the Scientific Committee jointly select up to 10 emerging clinical scientists. In the 2013 edition of the Rising Star awards two IDIBAPS investigators are among the winners: Dr.Augusto Villanueva, from the IDIBAPS Hepatocellular Carcinoma Translational Research Lab (BCLC group), and Dr. Francesc Balaguer, from the IDIBAPS Gastrointestinal and Pancreatic Oncology team.

    The awarded researchers are young and highly qualified professionals from around Europe with a relevant international-quality research. This initiative provides a durable platform for young researchers so that they can give state-of-the-art lectures and chair scientific sessions at UEG Week. The next one will take place on October 12-16, in Berlin.

More news



More events


Scientific Publications

More scientific publications

Heptromic Partners

Broad Institute, Harvard<br

Prof. Todd Golub

Broad Institute, Harvard Prof. Todd Golub

Sophisticated data mining

Project led by: Idibaps

Copyright © 2010 - 2014 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.